En español
NIDA

National Advisory Council Agenda

128th Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event, should contact Christine Salaita via email or phone at 301-827-5843 or through the Federal Relay (1-800-877-8339). Requests should be made at least five days in advance of the workshop.

February 6, 2018

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

9:00 a.m.

Call to Order
Nora Volkow, M.D. Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.,
Executive Secretary,
National Advisory Council on Drug Abuse,
Director, Division of Extramural Research, NIDA

9:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Division of Therapeutics and Medical Consequences (DTMC)
Ivan Montoya, M.P.H., M.D., Acting Director

10:15 a.m. Break

WebEx Information (Open Session Only)

Topic: WebEx - 128th Meeting, National Advisory Council on Drug Abuse
Date and Time: Tuesday, February 6, 2018 - 10:30 a.m. Eastern Daylight Time (New York, GMT-04:00), 7 hours
Url: https://nih.webex.com/nih/j.php?MTID=mc34f1176587efa18e55246439a4d4aaf
Meeting Number (Access Code):  620 714 561
Password: Success1

Join by phone:
1-650-479-3208 Call-in toll number (US/Canada)

Global call-in numbers:
https://nih.webex.com/nih/globalcallin.php?serviceType=MC&ED=637404942&tollFree=0

Can't join the meeting?
https://help.webex.com/docs/DOC-5412

Important Notice:  Please note that this WebEx service allows audio and other information sent during the session to be recorded, which may be discoverable in a legal matter. By joining this session, you automatically consent to such recordings. If you do not consent to being recorded, discuss your concerns with the host or do not join the session.​

Open Session

10:30 a.m. Welcome and Opening Remarks
Nora Volkow, M.D. Director, NIDA
10:40 a.m. Director's Report
Nora Volkow, M.D. Director, NIDA
11:30 a.m. Council Discussion​
Council Members
12:00 p.m. Lunch Break
1:15 p.m. The VA’s Future Research Agenda​
Rachel Ramoni, D.M.D., Sc.D.
Chief Research and Development Officer
Grant Huang, M.P.H., Ph.D.
Acting Director for the Cooperative Studies Program,
Office of Research and Development,
U.S. Department of Veterans Affairs
1:55 p.m. Enhancing Partnerships between NIDA and NICHD
Diana Bianchi, M.D.
Director, Eunice Kennedy Shriver National Institute of Child Health andHuman Development, NIH
2:35 p.m. Break
2:45 p.m. Cannabis Policy Workgroup Recommendations​
John Carnevale, Ph.D.
President and CEO, Carnevale Associates, LLC and
Current NACDA Council Member
3:15 p.m. ODS Strategic Planning
David Murray, Ph.D.
Director, Office of Disease Prevention, NIH
3:45 p.m. Concept Clearances​
NIDA Staff
4:15 p.m. Public Comments
4:30 p.m. Adjourn

This page was last updated January 2018